Detalhe da pesquisa
1.
Effectiveness and tolerability of citalopram for the treatment of depression and anxiety disorders in children and adolescents: an open-label study.
J Neural Transm (Vienna)
; 117(1): 139-45, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19851705
2.
Family-based association study of 5-HT(2A) receptor T102C polymorphism and suicidal behavior in Ashkenazi inpatient adolescents.
Int J Adolesc Med Health
; 17(3): 231-8, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-16231475
3.
Methylphenidate treatment for attention-deficit/hyperactivity disorder in children and adolescents with velocardiofacial syndrome: an open-label study.
J Clin Psychiatry
; 64(10): 1163-9, 2003 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-14658963
4.
DRD4 exon III polymorphism and response to risperidone in Israeli adolescents with schizophrenia: a pilot pharmacogenetic study.
Eur Neuropsychopharmacol
; 13(3): 183-5, 2003 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-12729944
5.
Additive effects of 5-HTTLPR (serotonin transporter) and tryptophan hydroxylase 2 G-703T gene polymorphisms on the clinical response to citalopram among children and adolescents with depression and anxiety disorders.
J Child Adolesc Psychopharmacol
; 23(2): 117-22, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23510446